Latest Clinical Breast Cancer Stories
Tokyo, Apr 23, 2012 - (JCN Newswire) - Eisai Co., Ltd.
Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.
Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.